Clever cancer strategies with FoxO transcription factors.
about
miRGen 2.0: a database of microRNA genomic information and regulationFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusShedding new light on neurodegenerative diseases through the mammalian target of rapamycinFoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryThe "O" class: crafting clinical care with FoxO transcription factors.Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Noncoding RNPs of viral originEPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndromeErythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohortIsotretinoin and FoxO1: A scientific hypothesis.Translating cell survival and cell longevity into treatment strategies with SIRT1Targeting cardiovascular disease with novel SIRT1 pathways.Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemiaThe impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancerPotential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acneThe forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3The vitamin nicotinamide: translating nutrition into clinical care.A fork in the path: Developing therapeutic inroads with FoxO proteins.Multidrug-resistant breast cancer: current perspectives.cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.The Roles of the Methyl-CpG Binding Proteins in Cancer.IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity.Role of Forkhead Box Class O proteins in cancer progression and metastasis.Caffeine-induced nuclear translocation of FoxO1 triggers Bim-mediated apoptosis in human glioblastoma cells.The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.FoxO proteins in the nervous system.
P2860
Q24644535-F7DDC33C-EFF9-4CA0-83EE-CA1624F11F49Q26800615-C09350E7-BB8F-4EA5-8B53-D03198A8FC56Q27015640-15CC393B-47E4-40E7-AFBF-5EC867C360F4Q33604706-8BDECE46-5E9E-42F2-B03A-00EEB1BCD86CQ33682262-EC16E55E-2F0D-471F-9AA3-4798095B42F0Q33717008-D7FACC32-025E-4BB1-94AE-DF93FD80ED8FQ33749358-D884CE33-64ED-494F-9D14-A21A3C07F9C8Q33824809-6D7B552E-3D89-4758-A0B7-0E1693800F7FQ33940076-3026C120-667F-4F63-8AD2-0776AC4E756CQ34514818-B7896E01-FC9A-40F5-9571-558503550C38Q34552287-815FC425-A059-466D-809E-FBFAC4E96440Q34578041-25D7FAD7-CC55-4B98-827B-C563B66C5F86Q34887803-C04B6FA3-8897-4EE8-B1A8-EB8E5F070082Q35121240-2F5E773A-C67A-497C-BA79-5AA0167C0502Q35146283-745C1524-1E99-4C83-BAAE-ED892D5F61B2Q35157985-27CD5E31-6F5B-493D-9E89-FEB7F2D03B4BQ35293249-F3D6613E-4A46-461A-A2B6-B23576A4ED9FQ35558873-D1E77AC7-27AD-4104-AA10-50DF5C384C1CQ35660308-85E5FFD5-0305-47C1-83FC-A8AA9AD86FA1Q35661632-688F038D-1126-4D09-903F-2C53926E0CE1Q36065874-3148A0F3-E5AF-4CDC-ACDA-DEADF91A983CQ36402333-64541454-9592-45DF-9084-2E8570F2D462Q37101729-B4B64473-D351-4D9D-9173-E1ABD13DD7BEQ37156425-844DCC70-A436-40CC-BF2E-F6B98AED4AF3Q37374047-64693509-994E-446A-B6C8-5E53DF3522B9Q37390262-166FDAD3-E14E-4833-A1C2-B83460F1706CQ37593383-2C8833E3-3789-40B6-A2F2-51617C110FB1Q37855854-F78CCDCC-A484-4DB5-B56F-F0B91FF44D50Q37937460-E98A8F42-F04F-49C7-9FE2-48D4B7E46570Q38247021-50BE2E4D-E5D0-4466-9F74-3C5BB7642F34Q38647185-D97770D8-E473-4317-9667-29B8957F8A6DQ38829384-A29F438A-520E-447D-B875-465ED789804CQ39066032-F4E93F97-D1C1-401B-A0A5-04E3BB4DED0AQ39721627-F625FC85-0DB5-40C9-AB7C-3CBE96911BAFQ40188778-251B4F86-2505-4CAD-9781-095B237D5AFCQ45305554-1C54B33D-DA7E-42F2-9A60-C7748C2E298CQ53622309-B7F0DA2B-505D-4F1E-B584-EDDE170172CE
P2860
Clever cancer strategies with FoxO transcription factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clever cancer strategies with FoxO transcription factors.
@en
Clever cancer strategies with FoxO transcription factors.
@nl
type
label
Clever cancer strategies with FoxO transcription factors.
@en
Clever cancer strategies with FoxO transcription factors.
@nl
prefLabel
Clever cancer strategies with FoxO transcription factors.
@en
Clever cancer strategies with FoxO transcription factors.
@nl
P2093
P2860
P356
P1433
P1476
Clever cancer strategies with FoxO transcription factors.
@en
P2093
Jinling Hou
Kenneth Maiese
Yan Chen Shang
Zhao Zhong Chong
P2860
P304
P356
10.4161/CC.7.24.7231
P577
2008-12-21T00:00:00Z